Isolation of broadly neutralizing anti-enterovirus antibodies from healthy adult donors

Open-label, single-arm trial of broadly neutralizing anti-enterovirus monoclonal antibodies in enteroviral infection, sponsored by Amsterdam University Medical Center. Primary endpoints: Serum neutralizing antibody titers against a panel of clinically relevant enteroviruses and Selection of paired PBMC samples for isolation of broadly neutralizing antibody-producing B cells. Planned start Jan 2017; status: withdrawn.